4.8 Article

One nanosystem with potent antibacterial and gene-delivery performances accelerates infected wound healing

Journal

NANO TODAY
Volume 39, Issue -, Pages -

Publisher

ELSEVIER SCI LTD
DOI: 10.1016/j.nantod.2021.101224

Keywords

Wound healing; Growth factor; Antibacterial; Gene delivery; Photodynamic therapy

Funding

  1. National Natural Science Foundation of China [51733001]
  2. Beijing Outstanding Young Scientist Program [BJJWZYJH01201910010024]
  3. Fundamental Research Funds for the Central Universities [XK1802-2]

Ask authors/readers for more resources

A new bifunctional nanosystem (HPT-RP) was developed for the treatment of infected wounds, with high antibacterial and gene delivery capabilities. By conjugating photosensitizers and bacterium/cell-affinity phenylboronic acid onto hyper branched polyaminoglycosides, HPT-RP showed great potential in combating infections and promoting gene transfection.
Growth factor delivery has attracted high attention for the treatment of severe skin wounds, while it is still desirable to develop new delivery systems with superiority for both antibacterial and delivery performances. In this work, one bifunctional nanosystem (HPT-RP) was constructed for the anti-bacterial and gene-delivery (plasmid encoding epidermal growth factor (EGF)) treatment of infected wound through the one-pot dual conjugation of photosensitizer and bacterium/cell-affinity phenylboronic acid onto hyper branched polyaminoglycosides. HPT-RP realized high anti-bacterial ability owing to the receptor-mediated photodynamic therapy. The nanoparticle morphology and phenylboronic acid conjugation endowed HPT-RP with high gene transfection. In a rat infected-skin-defect model, HPT-RP exhibited the remarkable performance of anti-infective/EGF-delivery and accelerated healing. More importantly, a new sight into rat-EGF production revealed the underlying mechanism of extraneous EGF delivery and endogenous EGF production. This work sheds light on the rational design of growth factor delivery systems for infected wound therapy. (c) 2021 Elsevier Ltd. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available